MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 206 filers reported holding MEDICINES CO in Q3 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $13,109,000 | +2537.6% | 154,334 | +1451.7% | 0.50% | +2168.2% |
Q3 2019 | $497,000 | -59.0% | 9,946 | -75.4% | 0.02% | -68.6% |
Q3 2018 | $1,211,000 | -18.7% | 40,500 | -0.2% | 0.07% | -25.5% |
Q2 2018 | $1,490,000 | +13.9% | 40,600 | +2.3% | 0.09% | -1.1% |
Q1 2018 | $1,308,000 | +30.7% | 39,700 | +8.5% | 0.10% | +18.8% |
Q4 2017 | $1,001,000 | +132.8% | 36,600 | +315.9% | 0.08% | +95.1% |
Q1 2017 | $430,000 | +523.2% | 8,800 | +384.0% | 0.04% | +485.7% |
Q3 2016 | $69,000 | -52.7% | 1,818 | -60.5% | 0.01% | -65.0% |
Q1 2016 | $146,000 | +80.2% | 4,601 | +58.7% | 0.02% | +81.8% |
Q1 2015 | $81,000 | +39.7% | 2,900 | +11.5% | 0.01% | +37.5% |
Q3 2014 | $58,000 | -33.3% | 2,600 | -13.3% | 0.01% | -33.3% |
Q2 2014 | $87,000 | +8.8% | 3,000 | +7.1% | 0.01% | +9.1% |
Q1 2014 | $80,000 | +128.6% | 2,800 | +211.1% | 0.01% | +83.3% |
Q4 2013 | $35,000 | -95.0% | 900 | -95.7% | 0.01% | -94.7% |
Q3 2013 | $704,000 | +2507.4% | 21,000 | +2525.0% | 0.11% | +2180.0% |
Q1 2013 | $27,000 | – | 800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |